136 related articles for article (PubMed ID: 34192607)
21. ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.
Knight ER; Patel EY; Flowers CA; Crowther AJ; Ting JP; Miller CR; Gershon TR; Deshmukh M
Oncogene; 2015 Jan; 34(3):394-402. PubMed ID: 24469054
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines.
Bonfim-Silva R; Ferreira Melo FU; Thomé CH; Abraham KJ; De Souza FAL; Ramalho FS; Machado HR; De Oliveira RS; Cardoso AA; Covas DT; Fontes AM
Int J Oncol; 2017 Dec; 51(6):1929-1940. PubMed ID: 29039487
[TBL] [Abstract][Full Text] [Related]
23. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.
Candia AF; Watabe T; Hawley SH; Onichtchouk D; Zhang Y; Derynck R; Niehrs C; Cho KW
Development; 1997 Nov; 124(22):4467-80. PubMed ID: 9409665
[TBL] [Abstract][Full Text] [Related]
24. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways.
Li J; Di C; Jing J; Di Q; Nakhla J; Adamson DC
Int J Oncol; 2015 Nov; 47(5):1703-10. PubMed ID: 26397460
[TBL] [Abstract][Full Text] [Related]
25. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
26. α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth.
Sengupta S; Weeraratne SD; Sun H; Phallen J; Rallapalli SK; Teider N; Kosaras B; Amani V; Pierre-Francois J; Tang Y; Nguyen B; Yu F; Schubert S; Balansay B; Mathios D; Lechpammer M; Archer TC; Tran P; Reimer RJ; Cook JM; Lim M; Jensen FE; Pomeroy SL; Cho YJ
Acta Neuropathol; 2014 Apr; 127(4):593-603. PubMed ID: 24196163
[TBL] [Abstract][Full Text] [Related]
27. A component of the ARC/Mediator complex required for TGF beta/Nodal signalling.
Kato Y; Habas R; Katsuyama Y; Näär AM; He X
Nature; 2002 Aug; 418(6898):641-6. PubMed ID: 12167862
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
Nagarajan RP; Zhang J; Li W; Chen Y
J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222
[TBL] [Abstract][Full Text] [Related]
29. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
30. BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta/activin signaling pathway.
Stewart A; Guan H; Yang K
J Cell Physiol; 2010 Jun; 223(3):658-66. PubMed ID: 20143330
[TBL] [Abstract][Full Text] [Related]
31. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
32. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors.
Northcott PA; Fernandez-L A; Hagan JP; Ellison DW; Grajkowska W; Gillespie Y; Grundy R; Van Meter T; Rutka JT; Croce CM; Kenney AM; Taylor MD
Cancer Res; 2009 Apr; 69(8):3249-55. PubMed ID: 19351822
[TBL] [Abstract][Full Text] [Related]
33.
Tao R; Murad N; Xu Z; Zhang P; Okonechnikov K; Kool M; Rivero-Hinojosa S; Lazarski C; Zheng P; Liu Y; Eberhart CG; Rood BR; Packer R; Pei Y
Cancer Res; 2019 Apr; 79(8):1967-1980. PubMed ID: 30862721
[TBL] [Abstract][Full Text] [Related]
34. Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer.
Staudacher JJ; Bauer J; Jana A; Tian J; Carroll T; Mancinelli G; Özden Ö; Krett N; Guzman G; Kerr D; Grippo P; Jung B
Sci Rep; 2017 Jul; 7(1):5569. PubMed ID: 28717230
[TBL] [Abstract][Full Text] [Related]
35. WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation.
Anne SL; Govek EE; Ayrault O; Kim JH; Zhu X; Murphy DA; Van Aelst L; Roussel MF; Hatten ME
PLoS One; 2013; 8(11):e81769. PubMed ID: 24303070
[TBL] [Abstract][Full Text] [Related]
36. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
[TBL] [Abstract][Full Text] [Related]
37. Role of MXD3 in proliferation of DAOY human medulloblastoma cells.
Barisone GA; Ngo T; Tran M; Cortes D; Shahi MH; Nguyen TV; Perez-Lanza D; Matayasuwan W; Díaz E
PLoS One; 2012; 7(7):e38508. PubMed ID: 22808009
[TBL] [Abstract][Full Text] [Related]
38. Identification of Two Protein-Signaling States Delineating Transcriptionally Heterogeneous Human Medulloblastoma.
Zomerman WW; Plasschaert SLA; Conroy S; Scherpen FJ; Meeuwsen-de Boer TGJ; Lourens HJ; Guerrero Llobet S; Smit MJ; Slagter-Menkema L; Seitz A; Gidding CEM; Hulleman E; Wesseling P; Meijer L; van Kempen LC; van den Berg A; Warmerdam DO; Kruyt FAE; Foijer F; van Vugt MATM; den Dunnen WFA; Hoving EW; Guryev V; de Bont ESJM; Bruggeman SWM
Cell Rep; 2018 Mar; 22(12):3206-3216. PubMed ID: 29562177
[TBL] [Abstract][Full Text] [Related]
39. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads.
Kumar A; Novoselov V; Celeste AJ; Wolfman NM; ten Dijke P; Kuehn MR
J Biol Chem; 2001 Jan; 276(1):656-61. PubMed ID: 11024047
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
